Srikanth Venkatraman

Srikanth is the Senior Vice President of Medicinal Chemistry and has twenty years of research experience in medicinal chemistry and drug discovery with particular expertise in the design of novel protease inhibitors. Prior to joining Disc Medicine, he worked at Schering Plough (later Merck) where he was the co-inventor of Victrelis and Arlansa, first generation HCV protease inhibitors. For these accomplishments, he received the Heroes of Chemistry award from the American Chemical Society. Srikanth received his doctoral degree from the University of Pittsburgh and did his postdoctoral training at the University of Illinois at Urbana Champaign.